Risk prediction model of cardiotoxicity in breast cancer patients; the multicenter prospective CHECK HEART-BC (comprehensive heart imaging to evaluate cardiac damage linked with chemotherapy in breast

Back

ESC Professional Premium Access

Risk prediction model of cardiotoxicity in breast cancer patients; the multicenter prospective CHECK HEART-BC (comprehensive heart imaging to evaluate cardiac damage linked with chemotherapy in breast

Session: Prediction and management of cardiovascular risk for patients with cancer

Topic: Cardio-Oncology

Speaker: Doctor Y. Terui (Sendai, JP)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Yosuke Terui

Tohoku University, Sendai (Japan)

0 follower

4 more presentations in this session

State-of-the-art lecture on prediction and management of cardiovascular risk in cancer patients

Speaker: Doctor A. Lyon (London, GB)

Access

Slides

Video

Androgen deprivation therapy for prostate cancer, measures of adiposity and strength, and adverse cardiovascular outcomes: observations from 3000 men in 5 countries in the RADICAL PC study

Speaker: Doctor D. Leong (Hamilton, CA)

Right ventricular free wall strain and tricuspid annular plane systolic excursion for the prediction of left sided cardiotoxicity in lymphoma patients treated with anthracycline-based chemotherapy.

Speaker: Doctor C. Ricaurte Carmona (Rochester, US)

Clinical features and long-term outcomes of cancer-associated venous thromboembolism: transition from the warfarin era to the direct oral anticoagulant era

Speaker: Doctor R. Chatani (Kurashiki, JP)

Access the full session

Prediction and management of cardiovascular risk for patients with cancer

Speakers: Doctor Y. Terui, Doctor A. Lyon, Doctor D. Leong, Doctor C. Ricaurte Carmona, Doctor R. Chatani

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Risk prediction model of cardiotoxicity in breast cancer patients; the multicenter prospective CHECK HEART-BC (comprehensive heart imaging to evaluate cardiac damage linked with chemotherapy in breast

About the speaker

Doctor Yosuke Terui

4 more presentations in this session

State-of-the-art lecture on prediction and management of cardiovascular risk in cancer patients

Androgen deprivation therapy for prostate cancer, measures of adiposity and strength, and adverse cardiovascular outcomes: observations from 3000 men in 5 countries in the RADICAL PC study

Right ventricular free wall strain and tricuspid annular plane systolic excursion for the prediction of left sided cardiotoxicity in lymphoma patients treated with anthracycline-based chemotherapy.

Clinical features and long-term outcomes of cancer-associated venous thromboembolism: transition from the warfarin era to the direct oral anticoagulant era

Access the full session

Prediction and management of cardiovascular risk for patients with cancer

About the event

ESC Congress 2023

ESC 365 is supported by